In Vivo LncRNA Inhibition in Human Tumor Xenografts Using Antisense Locked Nucleic Acid GapmeRs
Authors:
- 22 October 2026
- book chapter
- Published by Springer Nature
- Vol. 3091, 263-276
Abstract
Long noncoding RNAs (lncRNAs) have emerged as significant regulators of many physiological and pathological processes and play a key role in the onset and progression of a variety of diseases, including cancer. Currently, the functions of the majority of lncRNAs in carcinogenesis are still unclear. Functional characterization of specific lncRNAs is often challenging using the conventional RNA interference method, due to their specific and restricted subcellular localization. Antisense locked nucleic acid (LNA) GapmeRs, which induce RNase H1-mediated RNA cleavage, provide a promising strategy to knock down lncRNAs regardless of their intracellular localization. Here, we describe a protocol for suppressing the lncRNA BIN3 Intronic Transcript 1 (BIN3-IT1) in human breast cancer xenografts using Antisense LNA GapmeRs.Keywords
This publication has 32 references indexed in Scilit:
- Non-coding RNAs: the new central dogma of cancer biologyScience China Life Sciences, 2020
- Non-coding RNA in bladder cancerCancer Letters, 2020
- The Role of Non-coding RNAs in OncologyCell, 2019
- MicroRNAs and Long Non-coding RNAs in Genetic DiseasesMolecular Diagnosis & Therapy, 2019
- Long Noncoding RNA in Cancer: Wiring Signaling CircuitryTrends in Cell Biology, 2018
- RNA Interference to Knock Down Gene Expression2018
- Transcriptional and Post-Transcriptional Gene Regulation by Long Non-Coding RNAGenomics, Proteomics & Bioinformatics, 2017
- Roles, Functions, and Mechanisms of Long Non-Coding RNAs in CancerGenomics, Proteomics & Bioinformatics, 2016
- Oligonucleotide Therapeutics in Cancer2013
- siRNA vs. shRNA: Similarities and differencesAdvanced Drug Delivery Reviews, 2009